Options Update: Human Genome November volatility at 248 into data


Human Genome (NASDAQ: HGSI) closed at $19.97. HGSI's Benlysta, a lupus treatment, is expected to have phase 3 data released on November 2. HGSI November option implied volatility is at 249, December is at 170, January is at 143 and April is at 112, according to Track Data, suggesting large movement.

NASDAQ 100 (NASDAQ: QQQQ) overall implied volatility at 24; 26-week average is 28.

Semiconductor Holders Trust-SMH overall volatility at 29; 26-week average is 33.

Symbol Lookup
IndexesChangePrice
DJIA+33.0712,878.20
NASDAQ+2.092,904.08
S&P 500+2.721,347.05

Last updated: February 08, 2012: 12:46 AM

Hot Stocks

General Electric

19.18+0.13(+0.68)

Alcoa

10.67-0.065(-0.61)

Apple Inc

468.83+4.86(+1.05)

Google Inc 'A'

606.77-2.32(-0.38)

Bank of America

7.85-0.12(-1.51)

Wal-Mart Stores

61.69-0.19(-0.31)

Exxon Mobil Corp

86.34+0.59(+0.69)

Ford

12.88-0.08(-0.62)

Citigroup

33.07-0.23(-0.69)

IBM

193.35+0.53(+0.27)

Yahoo

15.83+0.01(+0.06)

Starbucks

48.41+0.12(+0.25)

Microsoft

30.35+0.15(+0.50)

Home Depot

45.46+0.26(+0.58)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines

    Page Loaded in 1328679962006 ms.